Subscribe
Subscribe

Industrial application

ImmunXperts: your partner for in vitro assays in cancer immunotherapy

Although immunotherapy in cancer is booming, it isn’t by any measure an easy field to navigate. Many oncology ventures willing to explore this new terrain [...]

Walloon radio-isotope technology in the fight against cancer

The leap from academia to industry

Dendritic cells boosted with mRNA form promising cancer immunotherapy

Leveraging 3D printing by sector wide collaboration

Under the guidance of Flam3D, the Flemish cluster association for 3D printing, 27 Flemish companies and research institutions collaborate on the realization of 'Family of the Future'. This will be a demonstration project aimed at clarifying what 3D printing technologies exist and how they can have real added value across a wide range of sectors.

IDO 1: a promising new target for immunotherapy

Reinforcing veins with computer simulations

Each year, more than two million patients worldwide undergo a procedure called coronary artery bypass grafting (CABG). CABG is used to treat blocked arteries and restore normal blood flow to the heart. It involves grafting a blood vessel — typically taken from the leg — around the diseased area, reestablishing blood flow to the heart tissue. However, veins used for CABG offer an inadequately durable solution to coronary artery disease, and the long-term outlook is not promising. Within 18 months, 25 percent of implanted veins fail. After 5 years, that failure rate increases to 40 percent. Angioshield, a novel type of external stent designed through ANSYS' computer simulations, offers a solution to this problem.

Diagnosing rare genetic conditions within minutes

Biocartis: ready for commercial boom

Biocartis CSO Geert Maertens gives an overview of the progress and future prospects of the company.

Strengthening communication in biotech companies

Many biotech management teams fail to reach out to investors in a clear and appealing way.

Janssen R&D focus enforced with new managing director

Unlocking patient data from medical reports

Stop eye-balling MRI scans

Up to 1 billion people in the world suffer from neurological disorders. Currently, many brain scans are still evaluated by visual inspection. Quantification of different biomarkers in these brain scans can improve diagnosis, patient monitoring and, eventually, patient outcome. The Leuven-based company Icometrix provides software to bring quantification of brain scans into clinical trials and clinical practice. We should stop eye-balling images of brain scans and step into the world of quantitative analysis.

MyCartis barcodes biological samples

CMAST: Bringing ideas from a risky early stage to a viable healthcare solution